A citation-based method for searching scientific literature

Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander, Lyle W Ostrow, David Schoenfeld, Eric A Macklin, Daniel A Norris, Georgios Manousakis, Matthew Crisp, Richard Smith, C Frank Bennett, Kathie M Bishop, Merit E Cudkowicz. Lancet Neurol 2013
Times Cited: 385



Andrew C Elden, Hyung-Jun Kim, Michael P Hart, Alice S Chen-Plotkin, Brian S Johnson, Xiaodong Fang, Maria Armakola, Felix Geser, Robert Greene, Min Min Lu, Arun Padmanabhan, Dana Clay-Falcone, Leo McCluskey, Lauren Elman, Denise Juhr, Peter J Gruber, Udo Rüb, Georg Auburger, John Q Trojanowski, Virginia M-Y Lee, Vivianna M Van Deerlin, Nancy M Bonini, Aaron D Gitler. Nature 2010
Times Cited: 758




List of shared articles



Times cited


Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.
Donya Pakravan, Gabriele Orlando, Valérie Bercier, Ludo Van Den Bosch. J Mol Cell Biol 2021
4

Antisense Drugs Make Sense for Neurological Diseases.
C Frank Bennett, Holly B Kordasiewicz, Don W Cleveland. Annu Rev Pharmacol Toxicol 2021
3

Gene therapy for ALS: A review.
Defne A Amado, Beverly L Davidson. Mol Ther 2021
4

Toxicity in ALS: TDP-43 modifiers and C9orf72.
Jessie L St Martin, Lina Wang, Zaven Kaprielian. Neurosci Lett 2020
2

Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
Ana C Silva, Diana D Lobo, Inês M Martins, Sara M Lopes, Carina Henriques, Sónia P Duarte, Jean-Cosme Dodart, Rui Jorge Nobre, Luis Pereira de Almeida. Brain 2020
18

The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future.
Heike J Wobst, Korrie L Mack, Dean G Brown, Nicholas J Brandon, James Shorter. Med Res Rev 2020
17

Studying ALS: Current Approaches, Effect on Potential Treatment Strategy.
E I Ustyantseva, S P Medvedev, S M Zakian. Adv Exp Med Biol 2020
2

Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis.
Yuan Chao Xue, Chen Seng Ng, Pinhao Xiang, Huitao Liu, Kevin Zhang, Yasir Mohamud, Honglin Luo. Front Mol Neurosci 2020
13


ALS Genetics: Gains, Losses, and Implications for Future Therapies.
Garam Kim, Olivia Gautier, Eduardo Tassoni-Tsuchida, X Rosa Ma, Aaron D Gitler. Neuron 2020
46

Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond.
Sara Nikseresht, James B W Hilton, Kai Kysenius, Jeffrey R Liddell, Peter J Crouch. Life (Basel) 2020
3


Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
38

[Genetics of Amyotrophic Lateral Sclerosis].
David Czell. Praxis (Bern 1994) 2019
0

Genetics of amyotrophic lateral sclerosis: A review.
Stéphane Mathis, Cyril Goizet, Antoine Soulages, Jean-Michel Vallat, Gwendal Le Masson. J Neurol Sci 2019
74